Drug Type Bispecific antibody |
Synonyms IL-12-Anti-Target B, KNP 102, KNP-102 |
Target |
Mechanism IL-12 replacements(Interleukin-12 replacements) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization KANAPH Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization KANAPH Therapeutics, Inc.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | KR | KANAPH Therapeutics, Inc.Startup | - |